# Stryker Corporation (SYK)

**Exchange:** NYSE  
**Sector:** Healthcare

> Stryker Corporation is a medical technology company that provides products and services designed to improve patient and healthcare outcomes worldwide. It operates primarily through two key segments: MedSurg and Neurotechnology, which encompasses surgical equipment, endoscopic devices, and neurology products; and Orthopaedics and Spine, focusing on joint replacement systems, trauma and extremities devices, and spinal implants. The company offers innovative solutions such as powered surgical instruments, patient handling equipment, and advanced neurovascular technologies that support healthcare professionals in hospitals, ambulatory surgery centers, and other clinical settings. Stryker Corporation serves a broad range of customers including hospitals, physicians, and healthcare institutions across various medical specialties. Founded in 1941 and headquartered in Portage, Michigan, it plays a significant role in the global medtech industry by delivering specialized instruments and implants that enhance surgical precision and patient recovery.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $25.12B | $16.07B | $4.89B | $3.25B | $8.40 |
| 2024 | $22.59B | $14.44B | $3.69B | $2.99B | $7.76 |
| 2023 | $20.50B | $13.06B | $3.89B | $3.17B | $8.25 |
| 2022 | $18.45B | $11.58B | $2.84B | $2.36B | $6.17 |
| 2021 | $17.11B | $10.97B | $2.58B | $1.99B | $5.21 |
| 2020 | $14.35B | $9.06B | $2.22B | $1.60B | $4.20 |
| 2019 | $14.88B | $9.70B | $2.71B | $2.08B | $5.48 |
| 2018 | $13.60B | $8.94B | $2.54B | $3.55B | $9.34 |
| 2017 | $12.44B | $8.18B | $2.30B | $1.02B | $2.68 |
| 2016 | $11.32B | $7.50B | $2.17B | $1.65B | $4.35 |
| 2015 | $9.95B | $6.60B | $1.86B | $1.44B | $3.78 |
| 2014 | $9.68B | $6.36B | $1.25B | $515M | $1.34 |
| 2013 | $9.02B | $6.02B | $1.26B | $1.01B | $2.63 |
| 2012 | $8.66B | $5.88B | $1.74B | $1.30B | $3.39 |
| 2011 | $8.31B | $5.50B | $1.69B | $1.34B | $3.45 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $47.84B | $25.42B | $22.42B | $4.01B | $14.86B |
| 2024 | $42.97B | $22.34B | $20.63B | $3.65B | $12.19B |
| 2023 | $39.91B | $21.32B | $18.59B | $2.97B | $10.90B |
| 2022 | $36.88B | $20.27B | $16.62B | $1.84B | $11.86B |
| 2021 | $34.63B | $19.75B | $14.88B | $2.94B | $12.47B |
| 2020 | $34.33B | $21.25B | $13.08B | $2.94B | $13.23B |
| 2019 | $30.17B | $17.36B | $12.81B | $4.34B | $10.23B |
| 2018 | $27.23B | $15.50B | $11.73B | $3.62B | $8.49B |
| 2017 | $22.20B | $12.22B | $9.97B | $2.54B | $6.59B |
| 2016 | $20.43B | $10.88B | $9.55B | $3.32B | $6.69B |
| 2015 | $16.22B | $7.71B | $8.51B | $3.38B | $3.23B |
| 2014 | $17.26B | $8.66B | $8.60B | $1.79B | $3.25B |
| 2013 | $15.40B | $6.35B | $9.05B | $1.34B | $2.74B |
| 2012 | $13.21B | $4.61B | $8.60B | $1.40B | $1.75B |
| 2011 | $12.15B | $4.46B | $7.68B | $905M | $1.77B |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $5.04B | $761M | $4.28B |
| 2024 | $4.24B | $755M | $3.49B |
| 2023 | $3.71B | $575M | $3.14B |
| 2022 | $2.62B | $588M | $2.04B |
| 2021 | $3.26B | $525M | $2.74B |
| 2020 | $3.28B | $487M | $2.79B |
| 2019 | $2.19B | $649M | $1.54B |
| 2018 | $2.61B | $572M | $2.04B |
| 2017 | $1.56B | $598M | $961M |
| 2016 | $1.92B | $490M | $1.43B |
| 2015 | $981M | $270M | $711M |
| 2014 | $1.78B | $233M | $1.55B |
| 2013 | $1.89B | $195M | $1.69B |
| 2012 | $1.66B | $210M | $1.45B |
| 2011 | $1.43B | $226M | $1.21B |

Source: [CompaniesByCap](https://companiesbycap.com/company/SYK)